{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:45:04Z","timestamp":1791755104093,"version":"4.3.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Nation Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001791"],"award-info":[{"award-number":["82001791"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Thiamine pyrophosphokinase (TPK) deficiency, is a rare autosomal recessive disorder of congenital metabolic dysfunction caused by variants in the <jats:italic>TPK1<\/jats:italic> gene. <jats:italic>TPK1<\/jats:italic> variants can lead to thiamine metabolic pathway obstacles, and its clinical manifestations are highly variable. We describe two cases of TPK deficiency with completely different phenotypes and different therapeutic effects, and 26 cases of previously reported were retrospectively reviewed to improve our understanding of the clinical and genetic features of the disease. Patients with TPK deficiency present with ataxia, dysarthria, dystonia, disturbance of consciousness, seizures, and other nervous system dysfunction. Different gene variant sites may lead to different clinical features and therapeutic effects. Gene analysis is important for the diagnosis of TPK deficiency caused by <jats:italic>TPK1<\/jats:italic> variants, and thiamine supplementation has been the mainstay of treatment for TPK deficiency to date.<\/jats:p>","DOI":"10.3389\/fped.2023.1173787","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T17:06:10Z","timestamp":1691600770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Thiamine pyrophosphokinase deficiency: report of two Chinese cases and a literature review"],"prefix":"10.3389","volume":"11","author":[{"given":"Dan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/j.1742-4658.2009.06966.x","article-title":"Reaction mechanisms of thiamin diphosphate enzymes: redox reactions","volume":"276","author":"Tittmann","year":"2009","journal-title":"FEBS J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/antiox11010042","article-title":"Thiamine as a possible neuroprotective strategy in neonatal hypoxic-ischemic encephalopathy","volume":"11","author":"Sechi","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jimd.12125","article-title":"Genetic defects of thiamine transport and metabolism: a review of clinical phenotypes, genetics, and functional studies","volume":"42","author":"Marce-Grau","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0167-4781(00)00264-5","article-title":"Molecular cloning of human thiamin pyrophosphokinase","volume":"1517","author":"Zhao","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jpba.2004.08.038","article-title":"Determination of thiamine and its phosphorylated forms in human plasma, erythrocytes and urine by HPLC and fluorescence detection: a preliminary study on cancer patients","volume":"37","author":"Losa","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"B6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S1474-4422(07)70104-7","article-title":"Wernicke\u2019s encephalopathy: new clinical settings and recent advances in diagnosis and management","volume":"6","author":"Sechi","year":"2007","journal-title":"Lancet Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24998","article-title":"Thiamine deficiency in childhood with attention to genetic causes: survival and outcome predictors","volume":"82","author":"Ortigoza-Escobar","year":"2017","journal-title":"Ann Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.ajhg.2011.11.007","article-title":"Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway","volume":"89","author":"Mayr","year":"2011","journal-title":"Am J Hum Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2014.09.010","article-title":"Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations","volume":"113","author":"Banka","year":"2014","journal-title":"Mol Genet Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymgmr.2013.12.007","article-title":"Thiamine pyrophosphokinase deficiency causes a leigh disease like phenotype in a sibling pair: identification through whole exome sequencing and management strategies","volume":"1","author":"Fraser","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1212\/WNL.0000000000004270","article-title":"Thiamine-responsive disease due to mutation of TPK1: importance of avoiding misdiagnosis","volume":"9","author":"Invernizzi CP","year":"2017","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jns.2017.02.063","article-title":"TPK1 Mutation induced childhood onset idiopathic generalized dystonia: report of a rare mutation and effect of deep brain stimulation","volume":"376","author":"Mahajan","year":"2017","journal-title":"J Neurolog Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00438-018-1517-3","article-title":"Reduced thiamine binding is a novel mechanism for TPK deficiency disorder","volume":"294","author":"Huang","year":"2019","journal-title":"Mol Genet Genomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/jpem-2018-0363","article-title":"Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing whole exome sequencing","volume":"32","author":"Zhu","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cca.2019.07.034","article-title":"Thiamine phosphokinase deficiency and mutation in TPK1 presenting as biotin responsive basal ganglia disease","volume":"499","author":"Nyhan","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/jcm8070991","article-title":"Utility of whole blood thiamine pyrophosphate evaluation in TPK1-related diseases","volume":"8","author":"Bugiardini","year":"2019","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s12031-020-01568-x","article-title":"Whole exome sequencing identifies a novel mutation of TPK1 in a Chinese family with recurrent ataxia","volume":"70","author":"Zhu","year":"2020","journal-title":"J Mol Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"104003","DOI":"10.1016\/j.ejmg.2020.104003","article-title":"Eleven novel mutations and clinical characteristics in seven Chinese patients with thiamine metabolism dysfunction syndrome","volume":"63","author":"Li","year":"2020","journal-title":"Eur J Med Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"106258","DOI":"10.1016\/j.clineuro.2020.106258","article-title":"Movement disorders associated with thiamine pyrophosphokinase deficiency: intrafamilial variability in the phenotype","volume":"199","author":"Au","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3760\/cma.j.cn511374-20191208-00627","article-title":"Analysis of clinical characteristics and gene variation in a family with thiamine pyrokinase deficiency","volume":"38","author":"Jue","year":"2021","journal-title":"Chinese J Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/14737159.2016.1222906","article-title":"Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases","volume":"16","author":"Bacchelli","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"B22","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3760\/cma.j.cn511374-20200428-00310","article-title":"Clinical characteristics and genetic analysis of a child with thiamine metabolic dysfunction syndrome type 5","volume":"38","author":"Shaowei","year":"2021","journal-title":"Chinese J Med Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1055\/s-0040-1715628","article-title":"Thiamine pyrophosphokinase deficiency due to mutations in the TPK1 gene: a rare, treatable neurodegenerative disorder","volume":"52","author":"Rusch","year":"2021","journal-title":"Neuropediatrics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0040-1715631","article-title":"Thiamine treatment and favorable outcome in an infant with biallelic TPK1 variants","volume":"52","author":"Eckenweiler","year":"2021","journal-title":"Neuropediatrics"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1173787\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T17:06:17Z","timestamp":1691600777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1173787\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":24,"alternative-id":["10.3389\/fped.2023.1173787"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1173787","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"article-number":"1173787"}}